Assessing teratogenic risks involves studying data from animal studies, epidemiological research, and case reports. These studies help determine the potential risks and guide recommendations for pregnant women. Regulatory agencies, such as the FDA, classify drugs based on their teratogenic risk to provide guidelines for use during pregnancy.
